Table 29.5—Medications Used to Prevent and Treat Osteoporosis
|
Medication |
Dosage |
Cost |
Special Considerations |
|
|
Bisphosphonates |
||||
|
|
Alendronate |
10 mg/d or 70 mg/week; 5 mg/d for prevention |
$$$$$ |
Adherence to dosing instructions required (Table 29.6); used in men and women to prevent glucocorticoid-induced osteoporosis |
|
|
Etidronate |
400 mg/day for 2 weeks every 3 months |
$$ |
May be used in men and women to prevent glucocorticoid-induced osteoporosis; use for idiopathic osteoporosis only if all other treatments are not tolerated or effective |
|
|
Ibandronate |
150 mg/month |
$$$$$ |
Must be taken fasting with water, standing upright and taking nothing by mouth for at least 60 minutes after taking; do not use if creatinine clearance is less than 30 mL/minute |
|
|
Risedronate |
5 mg/d |
$$$$$ |
Adherence to dosing instructions required (see Table 29.6) |
|
Selective estrogen receptor modulator |
||||
|
|
Raloxifene |
60 mg/d |
$$$$$ |
May prevent breast cancer |
|
Calcitonin |
||||
|
|
Nasal spray |
200 IU/d |
$$$$$ |
Metered spray; 1 spray gives daily dose; alternate nostrils each day to reduce side effects |
|
|
Injectable (subcutaneously or intramuscularly) |
50–100 IU 3 to 5 times/week |
$$$$ |
Injectable still useful, depending on patient |
|
Estrogen |
See text |
$ |
Not recommended as first-line choice |
|
|
Parathyroid hormone (teriparatide) |
20 μg/d (injection) |
$$$$$ |
For use in patients who cannot tolerate other approved treatments for osteoporosis |
|
NOTE: $ = approximately $10 per month.